Molecular detection of the ruminal bacterium, Butyrivibrio fibrisolvens, in feces from rural residents of southern India
暂无分享,去创建一个
[1] B. Ramakrishna,et al. Molecular Studies of Fecal Anaerobic Commensal Bacteria in Acute Diarrhea in Children , 2008, Journal of pediatric gastroenterology and nutrition.
[2] A. Rajić,et al. The Zoonotic Potential of Mycobacterium avium spp. paratuberculosis , 2008, Canadian journal of public health = Revue canadienne de sante publique.
[3] E. Boedeker,et al. Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections , 2008, Current opinion in gastroenterology.
[4] H. Furuya,et al. Effect of Oral Administration of Butyrivibrio fibrisolvens MDT-1, a Gastrointestinal Bacterium, on 3-Methylcholanthrene-Induced Tumor in Mice , 2007, Nutrition and cancer.
[5] B. Ramakrishna. The Normal Bacterial Flora of the Human Intestine and Its Regulation , 2007 .
[6] H. Flint,et al. Reduced Dietary Intake of Carbohydrates by Obese Subjects Results in Decreased Concentrations of Butyrate and Butyrate-Producing Bacteria in Feces , 2006, Applied and Environmental Microbiology.
[7] H. Flint,et al. Cell-associated alpha-amylases of butyrate-producing Firmicute bacteria from the human colon. , 2006, Microbiology.
[8] H. Furuya,et al. Effect of Oral Administration of Butyrivibrio fibrisolvens MDT-1 on Experimental Enterocolitis in Mice , 2006, Clinical and Vaccine Immunology.
[9] N. Asanuma,et al. Isolation of a novel strain of Butyrivibrio fibrisolvens that isomerizes linoleic acid to conjugated linoleic acid without hydrogenation, and its utilization as a probiotic for animals , 2006, Journal of applied microbiology.
[10] H. Furuya,et al. Oral administration of butyrivibrio fibrisolvens, a butyrate-producing bacterium, decreases the formation of aberrant crypt foci in the colon and rectum of mice. , 2005, The Journal of nutrition.
[11] M. Fukuoka,et al. The beneficial effects of microflora, especially obligate anaerobes, and their products on the colonic environment in inflammatory bowel disease. , 2005, Current pharmaceutical design.
[12] L M A Akkermans,et al. Gut flora in health and disease: potential role of probiotics. , 2005, Current issues in intestinal microbiology.
[13] A. Andoh,et al. Clostridium butyricum, a probiotic derivative, suppresses dextran sulfate sodium-induced experimental colitis in rats. , 2004, International journal of molecular medicine.
[14] S. Koike,et al. Phylogenetic analysis of fiber-associated rumen bacterial community and PCR detection of uncultured bacteria. , 2003, FEMS microbiology letters.
[15] S. Duncan,et al. Isolation and characteristics of a wheatbran‐degrading Butyrivibrio from human faeces , 1995, Letters in applied microbiology.
[16] R. B. Hespell,et al. Characterization of the cell wall of Butyrivibrio species. , 1993, Canadian journal of microbiology.
[17] R. B. Hespell,et al. Physiology and genetics of xylan degradation by gastrointestinal tract bacteria. , 1990, Journal of dairy science.
[18] W. Franklin,et al. Azoreductase activity of anaerobic bacteria isolated from human intestinal microflora , 1990, Applied and environmental microbiology.
[19] W. Roediger,et al. Bacterial short chain fatty acids: their role in gastrointestinal disease. , 1990, Digestive diseases.
[20] T. Gilat,et al. Is human methane production affected by long-term occupational exposure to a methanogenic flora? , 1986, Israel journal of medical sciences.